查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1637090

解剖病理學市場 - 全球產業分析、規模、佔有率、成長、趨勢及2032年預測

Anatomic Pathology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 195 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球解剖病理學市場規模預計將大幅擴大，預估2025年至2032年期間年複合成長率為 7.9%。隨著診斷技術的進步、慢性病盛行率的上升以及老年人口的不斷成長，市場規模預計將從2025年的40.7億美元擴大到2032年底的69.3億美元。

解剖病理學是病理學的一個重要分支，包括在顯微鏡下研究組織和細胞以識別疾病。此領域結合組織病理學、細胞學和免疫組織化學等技術來分析組織的結構和功能變化。它在指導治療方法、預測患者結果和提高對各種疾病的理解方面發揮關鍵作用。隨著醫療保健領域隨著新技術和人口結構的變化而發展，解剖病理學仍然是診斷和治療決策的基石。

影像、分子病理學和自動化方面的重大進步提高診斷的準確性和效率。數位病理學的採用實現了幻燈片數位化、遠端協作和人工智慧驅動的分析，實現更快、更準確的診斷。

本報告調查全球解剖病理學市場，提供市場概述，依產品/服務、應用、最終用途、地理的趨勢，和參與市場的公司的競爭趨勢。

目錄

第1章 執行摘要

第2章 市場概覽

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • COVID-19 影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • PESTLE 分析

第3章 全球解剖病理學市場展望，2019年～2032年

  • 2019年至2032年全球解剖病理學市場預測（依產品/服務、價值（十億美元））
  • 2019年至2032年全球解剖病理學市場應用預測、價值（十億美元）
  • 2019年至2032年全球解剖病理學市場預測（依最終用途、價值（十億美元））
  • 2019年至2032年全球解剖病理學市場預測（依地區劃分）價值（十億美元）

第4章 北美解剖病理學市場展望，2019年～2032年

第5章 歐洲解剖病理學市場展望，2019年～2032年

第6章 亞太地區解剖病理學市場展望，2019年～2032年

第7章 拉丁美洲解剖病理學市場展望，2019年～2032年

第8章 中東和非洲解剖病理學市場展望，2019年～2032年

第9章 競爭格局

  • 2025年公司市場佔有率分析
  • 競爭資訊中心
  • 公司簡介
    • BioGenex
    • Cardinal Health, Inc.
    • Sakura Finetek USA, Inc.
    • Quest Diagnostics Incorporated
    • Agilent Technologies
    • Bio SB
    • F. Hoffmann-La Roche AG
    • NeoGenomics
    • Laboratory Corporation of America Holdings

第10章 附錄

簡介目錄

The global anatomic pathology market is poised for substantial expansion, projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032. The market size is anticipated to rise from US$4.07 billion in 2025 to US$6.93 billion by the end of 2032, driven by technological advancements in diagnostics, increasing prevalence of chronic diseases, and a growing elderly population.

Understanding Anatomic Pathology

Anatomic pathology is a crucial discipline within pathology that involves the microscopic study of tissues and cells for disease identification. This field incorporates techniques such as histopathology, cytology, and immunohistochemistry to analyze structural and functional changes in tissues. It plays an essential role in guiding treatment approaches, predicting patient prognoses, and deepening the understanding of various diseases. As the healthcare sector evolves with new technologies and demographic shifts, anatomic pathology remains a cornerstone of diagnostic and therapeutic decision-making.

Market Insights

Key Drivers of Growth:

1.Innovations in Diagnostic Technologies:

  • Significant progress in imaging, molecular pathology, and automation has led to improved diagnostic precision and efficiency.
  • The adoption of digital pathology allows for slide digitization, remote collaboration, and AI-driven analysis, enabling faster and more accurate diagnoses.

2.Increasing Disease Burden:

  • The rising prevalence of cancer and other chronic conditions is fueling demand for precise and timely pathology services.
  • A growing aging population, more vulnerable to health issues, is further accelerating market growth.

Challenges Impacting the Market:

1.Telepathology Implementation and Regulatory Complexities:

  • While remote diagnostics and collaborative pathology offer numerous benefits, diverse regulatory requirements related to data privacy and diagnostic accuracy pose challenges.

2.Barriers to Technological Integration:

  • High costs, interoperability concerns, and the need for specialized staff training make the transition from conventional pathology to digital platforms more complex.

Business Opportunities

Advancements in Diagnostic Solutions:

  • The integration of digital pathology, AI, and molecular diagnostic techniques enhances diagnostic precision and operational efficiency.
  • AI-driven algorithms expedite data interpretation, generating actionable insights and reducing turnaround times.

Strategic Research Collaborations:

  • Partnerships between pathology labs, research institutions, and pharmaceutical firms drive innovation in diagnostic methodologies.
  • Collaborative efforts in biomarker discovery and companion diagnostics contribute to the growth of personalized medicine.

Regional Outlook

North America:

  • Leads the global market with a well-developed healthcare system, widespread disease awareness, and substantial investment in diagnostic technologies.
  • The U.S. has recorded a 24.3% increase in the adoption of advanced pathology services over the past three years, reinforcing market expansion.

Europe:

  • Pioneers in implementing advanced diagnostic technologies, with strong backing from research collaborations.
  • Nations like the UK emphasize sustainability and standardized pathology procedures, cementing Europe's position as a significant market player.

South Asia & Pacific:

  • Emerging as the fastest-growing region, driven by the rapid enhancement of healthcare infrastructure and rising disease prevalence.
  • Greater awareness of preventive healthcare practices is boosting demand for pathology services.

Latin America and Middle East & Africa:

  • These regions are experiencing steady growth due to improved healthcare accessibility and expanding diagnostic capabilities.

Competitive Landscape

Leading Market Players:

  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Sakura Finetek USA, Inc.
  • F. Hoffmann-La Roche AG
  • Cardinal Health, Inc.
  • BioGenex
  • NeoGenomics
  • Bio SB
  • Agilent Technologies

Market Segmentation

By Product and Service:

  • Anatomic Pathology Instruments
  • Anatomic Pathology Consumables
  • Anatomic Pathology Services

By Application:

  • Disease Diagnosis
  • Drug Discovery and Development
  • Other Applications

By End-User:

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Other Facilities

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Anatomic Pathology Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2025
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Anatomic Pathology Market Outlook, 2019 - 2032

  • 3.1. Global Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Anatomic Pathology Instruments
      • 3.1.1.2. Anatomic Pathology Consumables
      • 3.1.1.3. Anatomic Pathology Services
  • 3.2. Global Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Disease Diagnosis
      • 3.2.1.2. Drug Discovery and Development
      • 3.2.1.3. Others
  • 3.3. Global Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Research Laboratories
      • 3.3.1.3. Diagnostic Laboratories
      • 3.3.1.4. Others
  • 3.4. Global Anatomic Pathology Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Anatomic Pathology Market Outlook, 2019 - 2032

  • 4.1. North America Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Anatomic Pathology Instruments
      • 4.1.1.2. Anatomic Pathology Consumables
      • 4.1.1.3. Anatomic Pathology Services
  • 4.2. North America Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Disease Diagnosis
      • 4.2.1.2. Drug Discovery and Development
      • 4.2.1.3. Others
  • 4.3. North America Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Research Laboratories
      • 4.3.1.3. Diagnostic Laboratories
      • 4.3.1.4. Others
  • 4.4. North America Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 4.4.1.2. Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 4.4.1.3. Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 4.4.1.4. Canada Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 4.4.1.5. Canada Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 4.4.1.6. Canada Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Anatomic Pathology Market Outlook, 2019 - 2032

  • 5.1. Europe Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Anatomic Pathology Instruments
      • 5.1.1.2. Anatomic Pathology Consumables
      • 5.1.1.3. Anatomic Pathology Services
  • 5.2. Europe Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Disease Diagnosis
      • 5.2.1.2. Drug Discovery and Development
      • 5.2.1.3. Others
  • 5.3. Europe Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Research Laboratories
      • 5.3.1.3. Diagnostic Laboratories
      • 5.3.1.4. Others
  • 5.4. Europe Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.2. Germany Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. Germany Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. U.K. Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.5. U.K. Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. U.K. Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.7. France Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.8. France Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.9. France Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.10. Italy Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.11. Italy Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.12. Italy Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.13. Turkey Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.14. Turkey Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.15. Turkey Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.16. Russia Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.17. Russia Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.18. Russia Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.19. Rest of Europe Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.20. Rest of Europe Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.21. Rest of Europe Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Anatomic Pathology Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Anatomic Pathology Instruments
      • 6.1.1.2. Anatomic Pathology Consumables
      • 6.1.1.3. Anatomic Pathology Services
  • 6.2. Asia Pacific Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Disease Diagnosis
      • 6.2.1.2. Drug Discovery and Development
      • 6.2.1.3. Others
  • 6.3. Asia Pacific Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Research Laboratories
      • 6.3.1.3. Diagnostic Laboratories
      • 6.3.1.4. Others
  • 6.4. Asia Pacific Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.2. China Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. China Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. Japan Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.5. Japan Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. Japan Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. South Korea Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.8. South Korea Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. South Korea Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. India Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.11. India Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. India Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Southeast Asia Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.14. Southeast Asia Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Southeast Asia Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Rest of Asia Pacific Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.17. Rest of Asia Pacific Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Rest of Asia Pacific Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Anatomic Pathology Market Outlook, 2019 - 2032

  • 7.1. Latin America Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Anatomic Pathology Instruments
      • 7.1.1.2. Anatomic Pathology Consumables
      • 7.1.1.3. Anatomic Pathology Services
  • 7.2. Latin America Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Disease Diagnosis
      • 7.2.1.2. Drug Discovery and Development
      • 7.2.1.3. Others
  • 7.3. Latin America Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Research Laboratories
      • 7.3.1.3. Diagnostic Laboratories
      • 7.3.1.4. Others
  • 7.4. Latin America Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 7.4.1.2. Brazil Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. Brazil Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Mexico Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 7.4.1.5. Mexico Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Mexico Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. Argentina Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 7.4.1.8. Argentina Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. Argentina Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. Rest of Latin America Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 7.4.1.11. Rest of Latin America Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. Rest of Latin America Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Anatomic Pathology Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Anatomic Pathology Instruments
      • 8.1.1.2. Anatomic Pathology Consumables
      • 8.1.1.3. Anatomic Pathology Services
  • 8.2. Middle East & Africa Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Disease Diagnosis
      • 8.2.1.2. Drug Discovery and Development
      • 8.2.1.3. Others
  • 8.3. Middle East & Africa Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Research Laboratories
      • 8.3.1.3. Diagnostic Laboratories
      • 8.3.1.4. Others
  • 8.4. Middle East & Africa Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 8.4.1.2. GCC Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. GCC Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. South Africa Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 8.4.1.5. South Africa Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. South Africa Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Egypt Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 8.4.1.8. Egypt Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Egypt Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Nigeria Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 8.4.1.11. Nigeria Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Nigeria Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.13. Rest of Middle East & Africa Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 8.4.1.14. Rest of Middle East & Africa Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.15. Rest of Middle East & Africa Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2025
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. BioGenex
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Product and Service Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. Cardinal Health, Inc.
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Product and Service Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. Sakura Finetek USA, Inc.
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Product and Service Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. Quest Diagnostics Incorporated
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Product and Service Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. Agilent Technologies
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Product and Service Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. Bio SB
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Product and Service Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. F. Hoffmann-La Roche AG
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Product and Service Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. NeoGenomics
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Product and Service Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. Laboratory Corporation of America Holdings
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Product and Service Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations